Industry insights, integration guides, and product updates from the CXTMS team.

New U.S. tariffs on patented pharmaceutical imports are no longer just a trade-policy headline. With 100% duties, 120- to 180-day compliance windows, and country-specific carveouts, life sciences supply chains now need a logistics-led response.

Rail, intermodal, and truckload data all point to a broad industrial recovery in 2026, forcing shippers to rethink mode mix, capacity plans, and network assumptions.

SONAR’s new bulk contract-rate benchmarks give shippers a real reference point in one of trucking’s least transparent markets, just as freight pricing volatility is heating up again.

Cold-chain labor shortages are forcing 3PLs to redesign workflows, invest in automation, and build more resilient refrigerated operations instead of relying on old hiring playbooks.

The U.S. cold-storage market is still absorbing demand, but tenants are concentrating in newer automated facilities while older refrigerated buildings face record move-outs and rising competitive pressure.

E-commerce demand is reshaping parcel, LTL, trucking, and store-based fulfillment at once, forcing shippers to redesign freight networks around omnichannel speed and margin control.

As tariff pressure rises in 2026, the First Sale rule is giving some importers a legal way to lower duty exposure, but only if their documentation and governance are airtight.

March 2026 LMI data shows transportation capacity contracting to 39.2 while pricing surges to 89.4, a sharp warning that truckload conditions are tightening fast again.

Operational fatigue is becoming the defining supply chain risk of 2026 as disruption, AI adoption, and compliance pressure stack on top of already stretched teams.

Real-time edge data capture is moving warehouses beyond delayed scans, giving operators sharper visibility, faster exception response, and better handoffs into transportation execution.